Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28422713 | 0.81 | TSHR (0.54) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL18561873 | 0.81 | TSHR (0.54) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL18561874 | 0.81 | TSHR (0.54) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL27424409 | 0.80 | CYP1A2 (0.50) | TSHRTDP1ALDH1A1GAAL3MBTL1 | |
| SCHEMBL176227 | 0.79 | TSHR (0.47) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL3968417 | 0.79 | TSHR (0.47) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL176229 | 0.79 | TSHR (0.47) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL7783972 | 0.78 | TDP1 (0.64) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL14667033 | 0.78 | TSHR (0.47) | TSHRTDP1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL11599284 | 0.78 | TSHR (0.51) | TSHRTDP1SMN1; SMN2PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101019024-B | Taxol immunoassay method | SALADAX BIOMEDICAL INC | 2013-08-21 | — | — | CN | disclosed |
| EP-2315026-A2 | Taxol immunoassay | Saladax Biomedical Inc. (US) | 2011-04-27 | — | — | EP | disclosed |
| EP-2237035-A2 | Taxol derivatives for taxol immunoassay | Saladax Biomedical Inc. (US) | 2010-10-06 | — | — | EP | disclosed |
| EP-1771732-B1 | TAXOL IMMUNOASSAY | SALADAX BIOMEDICAL INC (US) | 2010-07-14 | — | — | EP | disclosed |
| US-20090221786-A1 | Taxol immunoassay | SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (CN) | 2009-09-03 | — | — | US | disclosed |
| EP-1771732-A4 | TAXOL IMMUNOASSAY | SALADAX BIOMEDICAL INC (US) | 2008-08-27 | — | — | EP | disclosed |
| CN-101019024-A | Taxol immunoassay method | SALADAX BIOMEDICAL INC (US) | 2007-08-15 | — | — | CN | disclosed |
| US-20070092922-A1 | Taxol immunoassay | SALADAX BIOMEDICAL INC. | 2007-04-26 | — | — | US | disclosed |
| EP-1771732-A2 | TAXOL IMMUNOASSAY | Saladax Biomedical Inc. (US) | 2007-04-11 | — | — | EP | disclosed |
| US-7175993-B2 | Taxol immunoassay | SALADAX BIOMEDICAL, INC. (US) | 2007-02-13 | — | — | US | disclosed |
| US-20060099665-A1 | Taxol immunoassay | SALADAX BIOMEDICAL INC. | 2006-05-11 | — | — | US | disclosed |
| WO-2006015098-A2 | TAXOL IMMUNOASSAY | SALADAX BIOMEDICAL INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| US-20060024769-A1 | Taxol immunoassay | SALADAX BIOMEDICAL INC. | 2006-02-02 | — | — | US | disclosed |
| US-20060024768-A1 | Taxol immunoassay | SALADAX BIOMEDICAL, INC. | 2006-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221786-A1 | Taxol immunoassay | TUBB6, TUBA1C, TUBB1 | TSHR 3736/4885TDP1 718/4885SMN1; SMN2 1467/4885 |
| US-20070092922-A1 | Taxol immunoassay | TUBB6, TUBA1C, TUBB1 | TSHR 3736/4885TDP1 718/4885SMN1; SMN2 1467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.